Citius Pharmaceuticals Inc (CTXRW) Stock Analysis

What Citius Pharmaceuticals Inc does

Citius Pharmaceuticals Inc. operates as an advanced-stage pharmaceutical company dedicated to the creation and commercialization of critical care therapeutics. Its strategic focus encompasses oncology, anti-infective agents for supportive cancer care, prescription drugs, and pioneering stem cell therapies. The company's pipeline features five distinct proprietary product candidates. Among these is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein currently undergoing Phase 3 clinical trials, designed to address persistent or recurrent cutaneous T-cell lymphoma. Also in Phase 3 development is Mino-Lok, an antibiotic lock solution aimed at resolving catheter-related bloodstream infections while preserving the infected catheter. Halo-Lido, a topical corticosteroid-lidocaine formulation in Phase 2b, seeks to deliver anti-inflammatory and anesthetic relief for individuals suffering from hemorrhoids. Additionally, Citius is advancing Mino-Wrap, a liquifying gel-based wrap formulated to mitigate tissue expander infections following breast reconstructive procedures, and NoveCite, a mesenchymal stem cell therapy intended for the treatment of acute respiratory distress syndrome. Cranford, New Jersey serves as the corporate headquarters for Citius Pharmaceuticals, which was established in 2007.

Key metrics

ETFs linked to CTXRW

Broad-market and Healthcare sector ETFs an investor holding Citius Pharmaceuticals Inc is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CTXRW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Citius Pharmaceuticals Inc?

Citius Pharmaceuticals Inc trades under the ticker CTXRW on NASDAQ.

Which exchange is CTXRW listed on?

CTXRW is listed on NASDAQ.

What sector does Citius Pharmaceuticals Inc operate in?

Citius Pharmaceuticals Inc is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CTXRW in a portfolio?

PortView shows CTXRW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.